Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Roche’s drug cocktail reduces hospitalisation due to COVID-19 in Phase III trial

March 24, 2021 Research and Development COVID-19, Roche, covid-19 treatment

Roche’s antibody drug combination of casirivimab and imdevimab has shown to reduce hospitalisation or death by 70% in non-hospitalised patients …
News

Pfizer and Myovant’s menstrual blood loss treatment reports 78% effectiveness

March 24, 2021 Research and Development Myovant, Pfizer, Phase III trial, fibroids, uterine fibroids

Pfizer and Myovant Science’s relugolix treatment to reduce menstrual blood loss in women with uterine fibroids has shown promising results …
News

Novo Nordisk obesity treatment successful in clinical trials

March 24, 2021 Research and Development Novo Nordisk, obesity

New results from Novo Nordisk’s Phase III study on obesity saw clinically relevant weight loss, without weight regain, in people …
News

Guerbet see positive Phase III results for MRI agent

March 24, 2021 Research and Development MRI

Medical imaging company, Guerbet, have announced the success of its Phase III study into the safety and efficacy of Gadopiclenol, …
News
covid-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 17, 2021 Research and Development COVID-19, covid-19 roundup, news roundup

The past week has seen a mix of good and bad COVID-19 news; the Oxford-AstraZeneca vaccine rollout has halted throughout …
News
Eli Lilly building

Lilly’s ulcerative colitis treatment meets all key endpoints in Phase III trial

March 17, 2021 Research and Development Eli Lilly, Phase III trial, lilly, mirikizumab, ulcerative colitis

Eli Lilly’s mirikizumab treatment for ulcerative colitis (UC) patients has met the primary endpoints and all key secondary endpoints in …
News

Axol Bioscience and CENSO Biotechnologies enter merger agreement

March 17, 2021 Research and Development Axol Bioscience, Censo Biotechnologies, immune cell, merger, neuroscience

Axol Bioscience, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO focused …
News

PEP-Therapy and Institut Curie’s cancer drug trial approved in France

March 17, 2021 Research and Development Cancer, France, Pep-therapy

PEP-Therapy and Institut Curie have been granted approval from the French National Agency for Medicines and Health Products (ANSM) to …
News

Medicago & GSK start plant-derived COVID-19 vaccine trial

March 17, 2021 Research and Development COVID-19, GSK

Medicago and GSK have announced the start of Phase III clinical testing of Medicago’s plant-derived COVID-19 vaccine. The vaccine candidate …
News
coronavirus

Pharmafile.com’s weekly COVID-19 news round-up

March 10, 2021 Research and Development COVID, COVID Vaccine, COVID-19, coronavirus, covid round-up

The past week has continued to see positive COVID-19 news; CytoDyn’s treatment for patients with severe symptoms of the virus …
News
lilly_entrance_web

Lilly’s cancer drug Retsevmo gets UK approval for multiple indications

March 10, 2021 Research and Development Cancer, Eli Lilly, MHRA

The MHRA has granted conditional marketing authorisation for Eli Lilly’s Retsevmo (selpercatinib) as monotherapy for a number of cancer indications.
News
Takeda building

Takeda acquire Maverick in $525m deal to expand cancer therapy portfolio

March 10, 2021 Research and Development Maverick, Takeda, cancer treatment

Takeda has acquired Maverick Therapeutics in a deal worth up to $525 million, in order to expand its portfolio of …
News
evonik__chemie_foto_001

Evonik and Cassava Sciences enter supply agreement for Alzheimer’s drug candidate

March 10, 2021 Research and Development Alzheimer's, Cassava Sciences, Evonik

Evonik has entered into an agreement to supply Cassava Sciences with large-scale, clinical-grade quantities of simufilam, a drug candidate for …
News

Affinivax receives $22m funding for development of Staphylococcus aureus vaccine

March 10, 2021 Research and Development Affinivax, bacteria, vaccines

Affinivax has received an award of $22 million funding from CARB-X, a global non-profit organisation, to develop a vaccine targeting Staphylococcus …
News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 3, 2021 Research and Development

The past week has continued to see positive COVID-19 news; COVAX has delivered their first batch of vaccines to Africa, …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026